Very early secondary acute myeloid leukemia in an adolescent patient with Ewing sarcoma of the sacrum: A case report and review of the literature
Treatment-related malignant neoplasms can darken the prognosis of a cancer patient. The previous chemotherapy load renders treatment challenging, especially when the second neoplasm develops shortly after the first one. We report the case of a 17-year-old male with Ewing sarcoma (ES) who developed what appeared to be treatment-related acute myeloid leukemia 2 months after the end of ES treatment and recurrence of ES during treatment of leukemia. We discuss the different therapeutic options considered. • Very early secondary acute myeloid leukemia in a pediatric patient with Ewing sarcoma of the sacrum: A case report and review of the literature • -Secondary neoplasms darken the prognosis of cancer patient • -This darkening is worst when the second neoplasm is developed shortly after the first one • -Treatment options are commonly limited in secondary neoplasms
Authors
- J. Orcajo Rincón (ORCID: https://orcid.org/0000-0003-4843-5786)
- Cristina Beléndez (ORCID: https://orcid.org/0000-0002-6019-6557)
- Ángel Lancharro (ORCID: https://orcid.org/0000-0001-9439-1951)
- Jesús Sánchez (ORCID: https://orcid.org/0000-0002-8769-6471)
- Blanca Tomás Soldevilla
Institutions
- Universidad Complutense de Madrid (ES)
- Instituto de Salud Carlos III (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Hospital General Universitario de Ciudad Real (ES)
- Spanish Research Group on Sarcomas (ES)
- Instituto de Investigación de Enfermedades Raras (ES)
Publication Details
- Journal
- Medical Reports
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1016/j.hmedic.2025.100283
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00